舍曲林合并阿立哌唑治疗难治性抑郁症的疗效和安全性(3)
[7] 张明园.精神科评定量表手册 [M].湖南：科学技术出版社，2003：121-126.
[8] 行为医学量表手册[M].中国行为医学科学编辑委员会编，2001：214-215.
[9] 翁永振，陈学诗.简明精神病学[M].北京：人民卫生出版社，1991：539-541.
[10] Burris KD，Molski TF，Xu C，et al.Aripiprazole，a novel antipsychotic，is a high-affinity partial agonist at human dopamine D2 receptors[J].J Pharmacol Exp Ther，2002，302(1)：381-359.
[11] Lawler CP，Prioleau C，Lewis MM，et al.Interactions of the novel antipsychotic aripiprazole(OPC-14597) with dopamine and serotonin receptor subtypes[J].Neuropsychopharmacology，1999，20(6)：612-627.
[12] Jordan s，Koprivica V，Chen R，et al.The antipsychotic aripiprazole is a potent，partial agonist at the human 5-TH1A receptor[J].Eur J Pharmacol，2002，441(3)：137-140.
[13] Bersani G，Pozzi F，Marini S，et al.5-HT2 receptor antagonsim in dysthymic disorder：a double-blind placebo-controlled study with ritanserin[J].Acta Psychiatr Scand，1991，83(4)：244-248.
[14] Bymaster FP，Rasmussen K，Calligaro DO，et al.In vitro and in vivo biochemistry of olanzapine：a novel atypical antipsychotic drug[J].J Clin Psychiatry，1997，58(Suppl 10)：28-36.
[15] Willner P.The mesolimbic dopamine system as a target for rapid antidepressant action[J].Int Clin Psychopharmacol，1997，12(Suppl 3)：7-14.
[16] Cleare A.Adjunctive aripiprazole improves symptoms in antidepressant refractory major depressive disorder[J].Evid Based Ment Health，2008，11(4)：111., 百拇医药(李海)
[8] 行为医学量表手册[M].中国行为医学科学编辑委员会编，2001：214-215.
[9] 翁永振，陈学诗.简明精神病学[M].北京：人民卫生出版社，1991：539-541.
[10] Burris KD，Molski TF，Xu C，et al.Aripiprazole，a novel antipsychotic，is a high-affinity partial agonist at human dopamine D2 receptors[J].J Pharmacol Exp Ther，2002，302(1)：381-359.
[11] Lawler CP，Prioleau C，Lewis MM，et al.Interactions of the novel antipsychotic aripiprazole(OPC-14597) with dopamine and serotonin receptor subtypes[J].Neuropsychopharmacology，1999，20(6)：612-627.
[12] Jordan s，Koprivica V，Chen R，et al.The antipsychotic aripiprazole is a potent，partial agonist at the human 5-TH1A receptor[J].Eur J Pharmacol，2002，441(3)：137-140.
[13] Bersani G，Pozzi F，Marini S，et al.5-HT2 receptor antagonsim in dysthymic disorder：a double-blind placebo-controlled study with ritanserin[J].Acta Psychiatr Scand，1991，83(4)：244-248.
[14] Bymaster FP，Rasmussen K，Calligaro DO，et al.In vitro and in vivo biochemistry of olanzapine：a novel atypical antipsychotic drug[J].J Clin Psychiatry，1997，58(Suppl 10)：28-36.
[15] Willner P.The mesolimbic dopamine system as a target for rapid antidepressant action[J].Int Clin Psychopharmacol，1997，12(Suppl 3)：7-14.
[16] Cleare A.Adjunctive aripiprazole improves symptoms in antidepressant refractory major depressive disorder[J].Evid Based Ment Health，2008，11(4)：111., 百拇医药(李海)